Estudio de biodisponibilidad comparativa de dos formulaciones de risperidona existentes en el mercado chileno

par Gaete,Leonardo E, Solís G,Jaime, Venegas F,Pablo, Carrillo C,Mitzy J, Schatloff B,Oscar, Saavedra S,Iván
Publié 2003

Priapismo secundario a antipsicóticos: a propósito de un caso asociado a risperidona

par Cruzado,Lizardo, Vallejos,César E
Publié 2012

PHARMACOKINETIC STUDY OF RISPERIDONE: APPLICATION OF A HPLC METHOD WITH SOLID PHASE EXTRACTION

par TORRES V,PABLO, SEPÚLVEDA C,M. JACQUELINE, VON PLESSING R,CARLOS
Publié 2011

SIMPLIFIED LIQUID-LIQUID EXTRACTION METHOD COUPLED WITH LC/DAD BY QUANTITATIVE DETERMINATION OF RISPERIDONE IN HUMAN SERUM

par Mennickent,Sigrid, Diego,Marta De, Liser,Bernd, Trujillo,Lina
Publié 2019

Dynamics of cognitive functions in treatment of alcohol-dependent patients

par T. V. Agibalova, O. V. Rychkova, A. G. Kuznetsov, G. L. Gurevich, R. K. Potapova
Publié 2013

STABILITY INDICATING HPLC METHOD FOR QUANTIFICATION OF RISPERIDONE IN TABLETS

par Mennickent,Sigrid, Diego,Marta de, Liser,Bernd, Trujillo,Lina
Publié 2018

Risperidone for children and adolescents with autism spectrum disorder: a systematic review

par Maneeton N, Maneeton B, Putthisri S, Woottiluk P, Narkpongphun A, Srisurapanont M
Publié 2018

Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis

par Sapunar Z,Jorge, Muñoz N,Sergio, Vásquez A,Tatiana
Publié 2009

A Machine Learning Model to Predict Risperidone Active Moiety Concentration Based on Initial Therapeutic Drug Monitoring

par Wei Guo, Wei Guo, Ze Yu, Ya Gao, Xiaoqian Lan, Xiaoqian Lan, Yannan Zang, Yannan Zang, Peng Yu, Zeyuan Wang, Wenzhuo Sun, Xin Hao, Fei Gao
Publié 2021

Priapism associated with Risperidone: A case report

par SH Hosseini, M Younesi Rostami, K Esmaeili
Publié 2006

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia

par Dhiren Singh, Daniel W O’Connor
Publié 2009

Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature

par Michele Fabrazzo, Mariangela Boccardi, Salvatore Cipolla, Raffaele Galiero, Claudia Tucci, Francesco Perris, Ester Livia Di Caprio, Francesco Catapano, Ferdinando Carlo Sasso
Publié 2021

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study

par Liang Y, Yu X
Publié 2017

Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospec...

par Alsayouf HA, Talo H, Biddappa ML, Qasaymeh M, Qasem S, De Los Reyes E
Publié 2020

Risperidone-induced reversible neutropenia

par Kattalai Kailasam V, Chima V, Nnamdi U, Sharma K, Shah K
Publié 2017

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report

par Narita Z, Takano H, Sumiyoshi T
Publié 2017

Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors

par De Santis M, Huang XF, Deng C
Publié 2018

c-Fos expression in the hypothalamic paraventricular nucleus after a single treatment with a typical haloperidol and nine atypical antipsychotics: a pilot study

par Kiss Alexander
Publié 2018

Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Ra...

par Wesołowska A, Rychtyk J, Gdula-Argasińska J, Górecka K, Wilczyńska-Zawal N, Jastrzębska-Więsek M, Partyka A
Publié 2021

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia

par Han JY, Li Y, Wang XM
Publié 2017